In 1970, Uragoda first reported a case of occupational asthma associated with tea fluff and designated tea maker's asthma.' Subsequently, several authors have described similar cases associated with tea dust or tea fluff.2-4 However, to our knowledge, no report has yet identified which tea component(s) cause the bronchial response.
In this study, we describe three patients with green tea-induced asthma and present data indicating that epigallocatechin gallate (EGCg), the major catechin component in green tea leaves, is a causative agent.
MATERIAL AND METHODS Subjects
Subjects consisted of three groups: nonatopic nonasthmatic volunteers (n=5), asthmatics with no previous exposure to green tea dust (asthmatic controls) (n=5), and patients with green teainduced asthma (n=3).
The clinical characteristics for patients with green tea-induced asthma are summarized in Table 1 . All patients had worked at different green tea factories in Shizuoka Prefecture. Their asthmatic symptoms (dyspnea, cough, and wheezing) and nasal symptoms (rhinorrhea and obstruction) began within 1 h after starting work and subsided on returning home. Furthermore, all three patients exhibited bronchial hyperresponsiveness as determined by an acetylcholine or methacholine inhalation test.56 Only one patient (patient 3) A powdered green tea extract was prepared by boiling 300 g of green tea leaves in water for 5 min and then allowing the extract to air dry.
Crude Catechins and Noncatechin Components: The procedure for purifying catechins is illustrated in Figure 1 . Briefly, the powdered green tea extract was dissolved in boiled water, followed by adding an equal portion of chloroform. After tProvocation concentration of acetylcholine causing a 20% fall in FEV1. tPC20 of methacholine.
tion. All skin test reactions were evaluated at 15 min and at 6 h postinjection. A positive reaction was defined as a flare greater than 20 mm and/or a wheal greater than 9 mm in diameter.7 Saline solution or 0.01% histamine base solution was employed as a negative or positive control, respectively.
Inhalation Challenge
Subjects were being treated with only intermittent 02-agonist inhalation before the study, and they were asked to not take that medication for at least 12 h prior to the inhalation challenge. Each tea component preparation was inhaled as a mist using a nebulizer (output: 0.16 mL/min) (Nisshyo, Tokyo, Japan) for 2 min. A 20% fall in FEV1 compared with the baseline value was evaluated as positive. To establish the reliability of the baseline values, changes in FEV1 after saline solution inhalation were evaluated hourly for 12 h. FEVy variability after saline solution inhalation was less than 5% in all subjects. Inhalation challenges with each preparation were subsequently performed. The concentration inhaled was increased in tenfold increments, from 10 ng/mL to 1 mg/mL. Open Oral Challenge Subjects were given an oral administration of 1 mL of powdered green tea extract dissolved in water at a concentration of 10 mg/mL, and spirometry values were taken over a 12-h period.
Prausnitz-Kuistner Test
With appropriate consent, serum was obtained from patients with green tea-induced asthma, and 0.1 mL of the serum was transferred intradermally into the back of a family member who previously had shown a negative skin reaction to powdered green tea extract or EGCg. Twenty-four hours later, each skin site was challenged by a 0.02 mL intradermal injection of powdered green tea extract or EGCg at a concentration of 1 mg/mL. As a control, other skin sites were sensitized with serum inactivated at 56°C for 2 h.
RESULTS

Skin Test
All patients with green tea-induced asthma showed an immediate positive reaction to powdered green tea extract, crude catechins, EGCg, and noncatechin components, and two of three patients had a positive reaction to EGC, ECg, and EC (Tables 2 and 3) . However, none of the normal and asthmatic controls reacted to these preparations (Table 2) . No late intradermal reactions were detected in any group. Inhalation Challenge Time courses of serial FEV1 measurements for the three patients with green tea-induced asthma were examined (Fig 2) (Fig 2) . Patients 1 and 2 exhibited no bronchial reaction to oral challenge.
Effects of Premedications on Bronchial Responses to Powdered Green Tea Extract
The effects of bronchodilators and disodium cromoglycate (DSCG) on the bronchial response to powdered green tea extract were studied in a singleblind way in patient 1. The patient received 300 mg of aminophylline orally 12 and 4 h prior to the inhalation. The blood level of aminophylline at the time of inhalation was 8.7 gg/mL. Salbutamol sulfate (1.5 mg) was inhaled 1 h before the challenge. Forty milligrams of DSCG was inhaled immediately before the challenge.
It was found that treatment with each medication completely inhibited IARs (Fig 3) .
Prausnitz-Kiistner Test
The Prausnitz-Kiistner (P-K) test revealed a positive reaction to powdered green tea extract and EGCg in each family member, while an injection of either saline solution or heat-treated serum caused no reaction.
Other Tea Extracts
All three patients with green tea-induced asthma had an isolated immediate skin reaction to the extracts from black tea and oolong tea. We also performed inhalation challenges with these tea extracts in patient 1, and he showed an isolated IAR (Fig 4) . DISCUSSION We have described three patients with green teainduced asthma and demonstrated that EGCg is a causative agent.
Tea is classified according to the method of manufacturing: unfermented tea (green tea), semifermented tea (oolong tea), and fermented tea (black tea). All three types are derived from the same tea plant, Camellia sinensis, and contain EGCg: 8% (green tea), 4% (oolong tea), and 1% (black tea) by weight.8 Thus, it is possible that EGCg is also a causative agent in black tea-associated asthmatic cases that have been previously reported."13'4 This would 1- ,, .
.C. be supported by the positive immediate skin reactions to black tea and oolong tea extracts demonstrated in our three patients and also the exhibited bronchial response to challenges with these extracts in one of the patients. These findings suggest that EGCg is a causative agent in several kinds of tea-associated asthma. However, there are some discrepancies between our cases and those previously reported by Roberts and Thompson3 and Cartier and Malo.4 They reported that skin prick tests to black tea dust extracts were negative, and that some of their patients showed late and prolonged immediate asthmatic responses. These discrepancies may result from different subjects studied, preparations tested, or methods used for challenges. It is known that the intradermal testing method that we used provides increased sensitivity compared with prick testing. Furthermore, they performed inhalation challenges by tipping tea dust between two containers, which may have resulted in inhalation of more tea products than our inhalation challenge.
Catechins are the source of the astringent taste of green tea and are the major soluble component of green tea, occupying 15% by weight of dried Japanese green tea leaves. Catechins consist of several different polyphenols, and EGCg accounts for more than half of the total catechin. Recent studies have shown that tea catechins have hypocholesterolemic,9 antioxidative,10 and antimutagenic1l effects.
Occupational asthma due to small molecular weight molecules remains complicated. Both immunologic and nonimmunologic mechanisms have been proposed. For example, occupational asthma induced by trimellitic anhydride is considered to be mediated by IgE, IgG, and nonspecific irritant stimulation. 12 In western red cedar induced asthma, air- way hyperreactivity may be related to a stimulicausing reflex, f-adrenergic blockade, direct activation of the complement pathway, and a specific IgE-mediated response.13 Our patients exhibited an immediate skin and bronchial response to EGCg, and a positive reaction to EGCg was shown in a P-K test. These findings indicate that an IgE-mediated reaction is, at least in part, responsible for causing bronchial and dermal responses in green tea-induced asthma. Since EGCg is a small molecular weight substance (458 daltons) (Fig 5) , one possibility is that it may act as a hapten by combining with a host protein(s).
Although coworkers of our patients in the same factories had no respiratory symptoms, it is probable that there are a certain number of workers suffering from the symptoms due to exposure to green tea dust in this area, where substantial amounts of green tea are produced and manufactured. The mechanisms and the prevalence of green tea-induced asthma should be investigated further because medications including administration of bronchodilators and DSCG enable patients to return to their workplaces when they cannot afford to change the job.
